Profile
Dr. Christophe Reymond is Chief Scientific Officer at Anergis SA.
Dr. Reymond was previously employed as an Assistant Professor by University of Lausanne, Chief Scientific Officer by Dictagene, and Researcher by University of California San Diego.
Former positions of Christophe Reymond
| Companies | Position | End |
|---|---|---|
| Dictagene | Founder | 31/12/2004 |
| University of Lausanne | Corporate Officer/Principal | 31/12/2000 |
| University of California San Diego | Corporate Officer/Principal | - |
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Health Technology |
| Dictagene |
- Stock Market
- Insiders
- Christophe Reymond
